Fairfield, Bush & Co’s Teladoc Health TDOC Stock Holding History
Bought
Maintained
Sold
Other funds holding TDOC
AIM
NAMA
GCGM
Fairfield, Bush & Co's TDOC Position: Q2 2021 in Review
Fairfield, Bush & Co sold out of Teladoc Health (TDOC) in Q2 2021, closing a stake of 1,400 shares — an estimated $254K sold.
Fairfield, Bush & Co first reported a position in TDOC in Q1 2021 and held it in 1 quarter. The position peaked at $254K in Q1 2021. 829 funds tracked by Wall St. Rank hold TDOC as of Q2 2021.
- Fairfield, Bush & Co reported no remaining Teladoc Health position as of Q2 2021 after selling out during the quarter.
- Fairfield, Bush & Co sold 1,400 Teladoc Health shares in Q2 2021, an estimated $254K.
- Fairfield, Bush & Co first reported a position in Teladoc Health in Q1 2021 and held it in 1 quarter.
- Fairfield, Bush & Co's Teladoc Health position peaked at $254K in Q1 2021.
- 829 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2021.
Based on Fairfield, Bush & Co's 13F filing for Q2 2021, filed 2 Aug 2021.